Lion Biotech Strikes $3.3M Deal In Stock-Drop Suit
A proposed investor class told a California federal court on Friday that it has inked a $3.25 million settlement with Lion Biotechnologies Inc. to resolve allegations that the company artificially inflated...To view the full article, register now.
Already a subscriber? Click here to view full article